Literature DB >> 18838620

AMP activated protein kinase 2 protection during hypertension-induced hypertrophy: a common mediator in the signaling crossroads.

Rogelio Zamilpa, Merry L Lindsey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18838620      PMCID： PMC2730971          DOI： 10.1161/HYPERTENSIONAHA.108.121244

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  10 in total

1.  Chronic matrix metalloproteinase inhibition following myocardial infarction in mice: differential effects on short and long-term survival.

Authors:  Francis G Spinale; G Patricia Escobar; Jennifer W Hendrick; Leslie L Clark; Sarah S Camens; Joseph P Mingoia; Christina G Squires; Robert E Stroud; John S Ikonomidis
Journal:  J Pharmacol Exp Ther       Date:  2006-06-06       Impact factor: 4.030

2.  Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism.

Authors:  Yulin Liao; Seiji Takashima; Norikazu Maeda; Noriyuki Ouchi; Kazuo Komamura; Iichiro Shimomura; Masatsugu Hori; Yuji Matsuzawa; Tohru Funahashi; Masafumi Kitakaze
Journal:  Cardiovasc Res       Date:  2005-09-01       Impact factor: 10.787

3.  Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy.

Authors:  Hong-Liang Li; Ran Yin; Dandan Chen; Dan Liu; Dong Wang; Qinglin Yang; Yu-Gang Dong
Journal:  J Cell Biochem       Date:  2007-04-01       Impact factor: 4.429

4.  AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury.

Authors:  Raymond R Russell; Ji Li; David L Coven; Marc Pypaert; Christoph Zechner; Monica Palmeri; Frank J Giordano; James Mu; Morris J Birnbaum; Lawrence H Young
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

Review 5.  Diastolic heart failure: mechanisms and controversies.

Authors:  Maral Ouzounian; Douglas S Lee; Peter P Liu
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-06-10

Review 6.  Role of heat shock transcriptional factor 1 and heat shock proteins in cardiac hypertrophy.

Authors:  Haruhiro Toko; Tohru Minamino; Issei Komuro
Journal:  Trends Cardiovasc Med       Date:  2008-04       Impact factor: 6.677

7.  AMP activated protein kinase-alpha2 deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction in mice.

Authors:  Ping Zhang; Xinli Hu; Xin Xu; John Fassett; Guangshuo Zhu; Benoit Viollet; Wayne Xu; Brian Wiczer; David A Bernlohr; Robert J Bache; Yingjie Chen
Journal:  Hypertension       Date:  2008-10-06       Impact factor: 10.190

Review 8.  Hypertrophy of the heart: a new therapeutic target?

Authors:  Norbert Frey; Hugo A Katus; Eric N Olson; Joseph A Hill
Journal:  Circulation       Date:  2004-04-06       Impact factor: 29.690

9.  Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte.

Authors:  Anita Y M Chan; Carrie-Lynn M Soltys; Martin E Young; Christopher G Proud; Jason R B Dyck
Journal:  J Biol Chem       Date:  2004-05-24       Impact factor: 5.157

10.  AMPK activation attenuates S6K1, 4E-BP1, and eEF2 signaling responses to high-frequency electrically stimulated skeletal muscle contractions.

Authors:  David M Thomson; Christopher A Fick; Scott E Gordon
Journal:  J Appl Physiol (1985)       Date:  2008-01-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.